Publications by authors named "Torsten Falk"

Claim this Profile
M
Motor cortex in levodopa-induced dyskinesia: Systems and molecular changes after sub-anesthetic ketamine treatment.
Torsten Falk, Stephen L Cowen

Neural Regen Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoupling of motor cortex to movement in Parkinson's dyskinesia rescued by sub-anaesthetic ketamine.
Abhilasha Vishwanath, Mitchell J Bartlett, Torsten Falk, Stephen L Cowen

Brain· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of statins on the anti-dyskinetic activity of sub-anesthetic ketamine.
Mitchell J Bartlett, Carolyn J Stopera, Stephen L Cowen, Scott J Sherman, Torsten Falk

Neurosci Lett· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The angiotensin (1-7) glycopeptide PNA5 improves cognition in a chronic progressive mouse model of Parkinson's disease through modulation of neuroinflammation.
Kelsey Bernard, Jesus A Mota, Paige Wene, Mandi J Corenblum, Juben L Saez, Torsten Falk

Exp Neurol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of statins on the anti-dyskinetic activity of sub-anesthetic ketamine.
Mitchell J Bartlett, Carolyn J Stopera, Stephen L Cowen, Scott J Sherman, Torsten Falk

bioRxiv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of opioid receptor antagonism on the anti-dyskinetic and anti-parkinsonian effects of sub-anesthetic ketamine treatment in a preclinical model.
Carolyn J Stopera, Mitchell J Bartlett, Chenxi Liu, Alexander Esqueda, Raveena Parmar, Torsten Falk

Neuropharmacology· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclic Glycopeptide Analogs of Endomorphin-1 Provide Highly Effective Antinociception in Male and Female Mice.
James E Zadina, Lajos Z Szabo, Fahad Al-Obeidi, Xing Zhang, Leticia Ferreira Nakatani, Torsten Falk

ACS Med Chem Lett· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PACAP glycosides promote cell outgrowth in vitro and reduce infarct size after stroke in a preclinical model.
Kelsey Bernard, Denali Dickson, Bobbi L Anglin, M Leandro Heien, Robin Polt, Torsten Falk

Neurosci Lett· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated system for training and assessing reaching and grasping behaviors in rodents.
Gianna A Jordan, Abhilasha Vishwanath, Gabriel Holguin, Mitchell J Bartlett, Andrew K Tapia, Torsten Falk

J Neurosci Methods· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonism of kappa opioid receptors accelerates the development of L-DOPA-induced dyskinesia in a preclinical model of moderate dopamine depletion.
Andrew J Flores, Mitchell J Bartlett, Blake T Seaton, Grace Samtani, Morgan R Sexauer, Torsten Falk

Brain Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonism of kappa opioid receptors accelerates the development of L-DOPA-induced dyskinesia in a preclinical model of moderate dopamine depletion.
Andrew J Flores, Mitchell J Bartlett, Blake T Seaton, Grace Samtani, Morgan R Sexauer, Torsten Falk

bioRxiv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated system for training and assessing string-pulling behaviors in rodents.
Gianna A Jordan, Abhilasha Vishwanath, Gabriel Holguin, Mitchell J Bartlett, Andrew K Tapia, Torsten Falk

bioRxiv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Based Design of Glycosylated Oxytocin Analogues with Improved Selectivity and Antinociceptive Activity.
Lajos Z Szabó, Parthasaradhireddy Tanguturi, Hannah J Goodman, Sára Sprőber, Chenxi Liu, Torsten Falk

ACS Med Chem Lett· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Synthesis of Brain Penetrant Glycopeptide Analogues of PACAP With Neuroprotective Potential for Traumatic Brain Injury and Parkinsonism.
Christopher R Apostol, Kelsey Bernard, Parthasaradhireddy Tanguturi, Gabriella Molnar, Mitchell J Bartlett, Torsten Falk

Front Drug Discov (Lausanne)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of microglia in a rodent model of Parkinson's disease primed with L-DOPA after sub-anesthetic ketamine treatment.
Ayumi E Pottenger, Mitchell J Bartlett, Scott J Sherman, Torsten Falk, Helena W Morrison

Neurosci Lett· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spectral signatures of L-DOPA-induced dyskinesia depend on L-DOPA dose and are suppressed by ketamine.
Tony Ye, Mitchell J Bartlett, Scott J Sherman, Torsten Falk, Stephen L Cowen

Exp Neurol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can quantifying morphology and TMEM119 expression distinguish between microglia and infiltrating macrophages after ischemic stroke and reperfusion in male and female mice?
Kimberly F Young, Rebeca Gardner, Victoria Sariana, Susan A Whitman, Mitchell J Bartlett, Torsten Falk

J Neuroinflammation· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Delta-Specific Opioid Glycopeptide BBI-11008: CNS Penetration and Behavioral Analysis in a Preclinical Model of Levodopa-Induced Dyskinesia.
Mitchell J Bartlett, Omar S Mabrouk, Lajos Szabò, Andrew J Flores, Kate L Parent, Torsten Falk

Int J Mol Sci· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesia.
Mitchell J Bartlett, Andrew J Flores, Tony Ye, Saskia I Smidt, Hannah K Dollish, Torsten Falk

Exp Neurol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep Spindles and Fragmented Sleep as Prodromal Markers in a Preclinical Model of LRRK2-G2019S Parkinson's Disease.
Lindsey M Crown, Mitchell J Bartlett, Jean-Paul L Wiegand, Allison J Eby, Emily J Monroe, Torsten Falk

Front Neurol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model.
Mitchell J Bartlett, Lisa Y So, Lajos Szabò, David P Skinner, Kate L Parent, Torsten Falk

BMC Res Notes· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction.
Meredith Hay, Robin Polt, Michael L Heien, Todd W Vanderah, Tally M Largent-Milnes, Torsten Falk

J Pharmacol Exp Ther· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten-Hour Exposure to Low-Dose Ketamine Enhances Corticostriatal Cross-Frequency Coupling and Hippocampal Broad-Band Gamma Oscillations.
Tony Ye, Mitchell J Bartlett, Matthew B Schmit, Scott J Sherman, Torsten Falk

Front Neural Circuits· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced l-DOPA-induced dyskinesia and MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesia.
Andrew J Flores, Mitchell J Bartlett, Brandon K Root, Kate L Parent, Michael L Heien, Torsten Falk

Neuropharmacology· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into the Mechanisms Involved in Protective Effects of VEGF-B in Dopaminergic Neurons.
Beatrice Caballero, Scott J Sherman, Torsten Falk

Parkinsons Dis· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis